Bioventus (BVS) Leases (2020 - 2026)

Bioventus (BVS) has 7 years of Leases data on file, last reported at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 62.14% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (down 62.14% YoY), and the FY2025 full-year result was $11.2 million, down 28.7% from the prior year.
• Leases for Q1 2026 stood at $4.7 million, down from $11.2 million in the prior quarter.
• Across five years, Leases topped out at $18.7 million in Q2 2022 and bottomed at $4.7 million in Q1 2026.
• The 5-year median for Leases is $15.1 million (2023), against an average of $14.3 million.
• The widest annual swing landed in 2024, when Leases climbed 7.26%; it then sank 62.14% in 2026.
• A 5-year view of Leases shows it stood at $16.7 million in 2022, then dropped by 5.71% to $15.7 million in 2023, then changed by 0.0% to $15.7 million in 2024, then retreated by 28.7% to $11.2 million in 2025, then plunged by 58.23% to $4.7 million in 2026.
• The last three Leases figures came in at $4.7 million (Q1 2026), $11.2 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.

Peer Comparison